Tag: UT Arlington
-
SDMA as a Predictor of Cardiovascular Risk in CKD Patients
New findings reshape how we view blood markers in CKD and cardiovascular risk When researchers at the University of Texas at Arlington set out to understand why people with chronic kidney disease (CKD) often die from heart problems rather than kidney failure, they revisited a long-standing assumption about blood markers. For years, scientists highlighted ADMA…
-
Inactive SDMA Emerges as Potential Predictor of Cardiovascular Risk in CKD
New Findings Reframe SDMA’s Role in CKD-Related Cardiovascular Risk When researchers at the University of Texas at Arlington set out to understand why people with chronic kidney disease (CKD) are at heightened risk for heart problems, they revisited a long-standing assumption. For years, ADMA—asymmetric dimethylarginine—has been considered a warning sign for vascular dysfunction. But a…
-
SDMA Emerges as Predictor of Cardiovascular Risk in CKD
New insight into SDMA and cardiovascular risk in chronic kidney disease Chronic kidney disease (CKD) is a condition where the risk of heart and blood vessel problems often overshadows the dysfunction of the kidneys themselves. For years, researchers have highlighted ADMA — asymmetric dimethylarginine — as a warning sign of vascular trouble. But a recent…